218 related articles for article (PubMed ID: 28845081)
1. Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia.
Korpelainen S; Intke C; Hämäläinen S; Jantunen E; Juutilainen A; Pulkki K
Dis Markers; 2017; 2017():9805609. PubMed ID: 28845081
[TBL] [Abstract][Full Text] [Related]
2. Asymmetric dimethylarginine in the assessment of febrile neutropenia in hematological patients.
Lappalainen M; Hämäläinen S; Juutilainen A; Koivula I; Pulkki K; Jantunen E
Scand J Clin Lab Invest; 2017 Apr; 77(2):130-134. PubMed ID: 28218011
[TBL] [Abstract][Full Text] [Related]
3. IL-10 combined with procalcitonin improves early prediction of complications of febrile neutropenia in hematological patients.
Vänskä M; Koivula I; Jantunen E; Hämäläinen S; Purhonen AK; Pulkki K; Juutilainen A
Cytokine; 2012 Dec; 60(3):787-92. PubMed ID: 22902948
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of sTREM-1, IL-8, PCT, and CRP in febrile neutropenia after autologous stem cell transplantation.
Michel CS; Teschner D; Wagner EM; Theobald M; Radsak MP
Ann Hematol; 2017 Dec; 96(12):2095-2101. PubMed ID: 28920169
[TBL] [Abstract][Full Text] [Related]
5. Plasma level of interleukin-18 and complicated course of febrile neutropenia in hematological patients after intensive chemotherapy.
Korpelainen S; Hämäläinen S; Vänskä M; Koivula I; Pulkki K; Jantunen E; Juutilainen A; Purhonen AK
Cytokine; 2020 May; 129():155021. PubMed ID: 32087594
[TBL] [Abstract][Full Text] [Related]
6. The predictive value of procalcitonin, C-reactive protein, presepsin, and soluble-triggering receptor expressed on myeloid cell levels in bloodstream infections in pediatric patients with febrile neutropenia.
Özdemir ZC; Düzenli-Kar Y; Canik A; Küskü-Kiraz Z; Özen H; Bör Ö
Turk J Pediatr; 2019; 61(3):359-367. PubMed ID: 31916713
[TBL] [Abstract][Full Text] [Related]
7. Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies.
Baraka A; Zakaria M
Int J Hematol; 2018 Aug; 108(2):184-191. PubMed ID: 29616457
[TBL] [Abstract][Full Text] [Related]
8. Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients.
Koizumi Y; Shimizu K; Shigeta M; Okuno T; Minamiguchi H; Kito K; Hodohara K; Yamagishi Y; Andoh A; Fujiyama Y; Mikamo H
BMC Infect Dis; 2017 Jan; 17(1):27. PubMed ID: 28056845
[TBL] [Abstract][Full Text] [Related]
9. Novel Biomarker Candidates for Febrile Neutropenia in Hematological Patients Using Nontargeted Metabolomics.
Lappalainen M; Jokkala J; Juutilainen A; Hämäläinen S; Koivula I; Jantunen E; Hanhineva K; Pulkki K
Dis Markers; 2018; 2018():6964529. PubMed ID: 29849825
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes.
Jeddi R; Achour M; Amor RB; Aissaoui L; Bouterâa W; Kacem K; Lakhal RB; Abid HB; BelHadjAli Z; Turki A; Meddeb B
Hematology; 2010 Feb; 15(1):28-32. PubMed ID: 20132659
[TBL] [Abstract][Full Text] [Related]
11. A high angiopoietin-2/angiopoietin-1 ratio is associated with a high risk of septic shock in patients with febrile neutropenia.
Luz Fiusa MM; Costa-Lima C; de Souza GR; Vigorito AC; Penteado Aranha FJ; Lorand-Metze I; Annichino-Bizzacchi JM; de Souza CA; De Paula EV
Crit Care; 2013 Aug; 17(4):R169. PubMed ID: 23915833
[TBL] [Abstract][Full Text] [Related]
12. Serum caspase-cleaved cytokeratin-18 fragment as a prognostic biomarker in hematological patients with febrile neutropenia.
Intke C; Korpelainen S; Lappalainen M; Vänskä M; Hämäläinen S; Pulkki K; Jantunen E; Juutilainen A; Purhonen AK
Clin Exp Med; 2022 Feb; 22(1):83-93. PubMed ID: 34255216
[TBL] [Abstract][Full Text] [Related]
13. The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies.
Kaya S; Köksal I; Menteşe A; Sönmez M; Sümer A; Yıldırım SS; Yılmaz G
Int J Infect Dis; 2013 Nov; 17(11):e1056-9. PubMed ID: 23742830
[TBL] [Abstract][Full Text] [Related]
14. Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia.
Koivula I; Hämäläinen S; Jantunen E; Pulkki K; Kuittinen T; Nousiainen T; Juutilainen A
Scand J Infect Dis; 2011 Jul; 43(6-7):471-8. PubMed ID: 21299364
[TBL] [Abstract][Full Text] [Related]
15. Human plasma cell-free DNA as a predictor of infectious complications of neutropenic fever in hematological patients.
Purhonen AK; Juutilainen A; Vänskä M; Lehtikangas M; Lakkisto P; Hämäläinen S; Koivula I; Jantunen E; Pulkki K
Infect Dis (Lond); 2015 Apr; 47(4):255-9. PubMed ID: 25664374
[TBL] [Abstract][Full Text] [Related]
16. Measurements of procalcitonin facilitate targeting of endotoxin adsorption treatment in febrile neutropenic patients suffering from shock.
Hara M; Tsuchiya K; Nitta K; Ando M
Clin Nephrol; 2014 Jan; 81(1):67-70. PubMed ID: 22909782
[TBL] [Abstract][Full Text] [Related]
17. High pentraxin 3 level predicts septic shock and bacteremia at the onset of febrile neutropenia after intensive chemotherapy of hematologic patients.
Vänskä M; Koivula I; Hämäläinen S; Pulkki K; Nousiainen T; Jantunen E; Juutilainen A
Haematologica; 2011 Sep; 96(9):1385-9. PubMed ID: 21880642
[TBL] [Abstract][Full Text] [Related]
18. Plasma copeptin in the assessment of febrile neutropenia.
Purhonen AK; Vänskä M; Hämäläinen S; Pulkki K; Lehtikangas M; Kuittinen T; Nousiainen T; Koivula I; Jantunen E; Juutilainen A
Peptides; 2012 Jul; 36(1):129-32. PubMed ID: 22580173
[TBL] [Abstract][Full Text] [Related]
19. Serum interleukin-33 and soluble suppression of tumorigenicity 2 in pediatric leukemia with febrile neutropenia.
Polat MC; Sönmez Ç; Yarali N; Özbek NY
Eur J Pediatr; 2024 May; 183(5):2155-2162. PubMed ID: 38367066
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD14 Subtype-A New Biomarker in Predicting the Outcome of Critically Ill Septic Patients.
Matera G; Quirino A; Peronace C; Settembre P; Marano V; Loria MT; Marascio N; Galati L; Barreca GS; Giancotti A; Amantea B; Liberto MC; Focà A
Am J Med Sci; 2017 Jun; 353(6):543-551. PubMed ID: 28641717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
